Thanks to Treed, I was looking at the clincialtrials.gov site from the DREAM-HF1 study.
It was last updated on April 5 2019. At that time, it predicted the completion date to be December 2019.
I'm not sure what information they had available to them (probably the number of MACE), but they were accurate with the predicted completion date. If, as some have suggested form hearing SI at the AGM, the initial futility analysis found an effective product, this bodes well that the trial on the whole was positive.
Just a thought.
MSB Trading - 2020, page-199
-
- There are more pages in this discussion • 22,962 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.101B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 99.5¢ | 96.0¢ | $2.283M | 2.340M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29300 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |